Polar Asset Management Partners’s Cidara Therapeutics CDTX Stock Holding History

Polar Asset Management Partners’s Portfolio CDTX Stock Details CDTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-216,998	Closed	-$47.9M	–	714
2025 Q4	$47.9M	Buy	+216,998	New	+$35.1M	0.61%	35

Polar Asset Management Partners's CDTX Position: Q1 2026 in Review

Polar Asset Management Partners sold out of Cidara Therapeutics (CDTX) in Q1 2026, closing a stake of 216,998 shares — an estimated $47.9M sold.

Polar Asset Management Partners first reported a position in CDTX in Q4 2025 and held it in 1 quarter. The position peaked at $47.9M in Q4 2025. 0 funds tracked by Wall St. Rank hold CDTX as of Q1 2026.

Polar Asset Management Partners reported no remaining Cidara Therapeutics position as of Q1 2026 after selling out during the quarter.
Polar Asset Management Partners sold 216,998 Cidara Therapeutics shares in Q1 2026, an estimated $47.9M.
Polar Asset Management Partners first reported a position in Cidara Therapeutics in Q4 2025 and held it in 1 quarter.
Polar Asset Management Partners's Cidara Therapeutics position peaked at $47.9M in Q4 2025.
0 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q1 2026.

Based on Polar Asset Management Partners's 13F filing for Q1 2026, filed 15 May 2026.